Anti-Microglial Hyperactivity Drug Action May Block Alzheimer’s Disease Progression

Vignesh Subramanian ’24 Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive loss of memory, critical thinking skills, and behavioral capabilities that typically worsens with age. As the most common form of late-stage dementia, numerous risk alleles – variants of a gene that make a particular disease’s development more likely – have been identified for AD. Prominent among these is the triggering receptor expressed … Continue reading Anti-Microglial Hyperactivity Drug Action May Block Alzheimer’s Disease Progression

Microglial Activation Promotes AD-Affiliated Plaque Formation

Vignesh Subramanian ’24 Alzheimer’s disease (AD) is a neurodegenerative disorder and form of dementia that causes progressive loss of memory, critical thinking skills, and behavioral capabilities. The disease is characterized by the extracellular aggregation of beta (β)-amyloid plaques. These buildups gradually interfere with proteostasis, the regulation of protein synthesis and degradation, and decrease levels of neurotransmitter signaling between neurons. However, the failure of microglia – … Continue reading Microglial Activation Promotes AD-Affiliated Plaque Formation